我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

干预非糖尿病患者胰岛素抵抗对冠脉支架植入术后的影响(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2008年第1期
页码:
65-67，70
栏目:
临床研究
出版日期:
2008-01-20

文章信息/Info

Title:
Effect of metformin on acute cardiovascular events and restenosis after percutaneous coronary intervention in nondiabetic patients with insulin resistance
作者:
王旭辉; 郑欢; 沈艺; 罗明
同济大学附属同济医院心内科，上海 200065
Author(s):
WANG Xuhui;  ZHENG Huan;  SHEN Yi;  LUO Ming
Department of Cardiology, Tongji Hospital, Tongji University, Shanghai 200065, China
关键词:
胰岛素抵抗; 支架植入术; 急性心血管事件; 再狭窄
Keywords:
insulin resistance;  percutaneous coronary intervention;  acute cardiovascular events;  restenosis
分类号:
R977.15;R541.4
DOI:
-
文献标识码:
A
摘要:
目的 观察二甲双胍干预非糖尿病患者胰岛素抵抗(insulin resestence,IR)对冠状动脉支架植入术（percutaneous coronary intervention,PCI）后急性心血管事件以及冠脉支架再狭窄的影响。方法 对97例冠状动脉病变接受PCI术并发IR的非糖尿病患者随机分成2组，一组在基础治疗的基础上加用二甲双胍片（0.5 g,3次/d,口服）作为试药组,另一组仅作基础治疗为对照组，观察两组支架植入术后一年的急性心血管事件(心绞痛、心肌梗死、心因性死亡)及支架内再狭窄的发生率。结果 术后1年11例失访。86例随访中，试药组（n=41）5例发生心绞痛，无心肌梗死发生，造影复查47处植入支架发现再狭窄6例，即再狭窄发生率为13%（6/47）；对照组（n=45）14例发生心绞痛，2例发生心肌梗死（ST段抬高、非ST段抬高各1例），造影复查53例植入支架发现再狭窄10例，另有2例出现新的冠脉狭窄（病变的狭窄程度≥50%），即再狭窄发生率为30 %（16/53）。急性心血管事件和支架内再狭窄发生率试药组低于对照组 (均P<0.05)。结论 在非糖尿病患者伴IR行PCI术后应用二甲双胍进行干预可以降低患者的急性心血管事件以及冠脉支架再狭窄发生率。
Abstract:
AIM To investigate the effects of metformin on acute cardiovascular events and restenosis after percutaneous coronary intervention（PCI） in nondibetic patients with insulin resistance（IR）. METHODS Ninetyseven nondiabetic patients with IR after successful PCI were enrolled and randomized into two groups: treatment group and control group. The patients in the treatment group orally took metformin 0.5g three times a day besides the basal therapy after PCI, while the control group only received routine treatment. Followup coronary angiography (CAG) was performed about 1 year after PCI and acute cardiovascular events (angina pectoris, myocardial infarction, cardiac death) and restenosis after PCI were carefully observed in about 1 year. RESULTS Of the 97 patients, 86 completed the regimen. In the treatment group (n=41), angina pectoris was found in 5 cases without myocardial infarction and followup CAG showed 6 lesions of restenosis in 47 original lesions. In the control group (n=45), angina pectoris was found in 14 cases of and myocardial infarction in 2 cases and followup CAG showed 10 lesions of restenosis as well as 2 new stenosis in 53 original lesions. After the oral metformin intervention there was a decrease in the incidence of acute cardiovascular events and restenosis after PCI （all P<0.05）. CONCLUSION Metformin decreases acute cardiovascular events and restenosis after PCI in nondiabetic patients with IR.

参考文献/References

［1］ 陈名道. 2型糖尿病及IGT人群心血管疾病的预防策略［J］.国外医学·内分泌分册，2004，24（2）：137－139.

［2］ Reaven G. Insulin Resistance, Hypertension, and Coronary Heart Disease［J］. J Clin Hypertens (Greenwich) ,2003 ,5(4):269-274.

［3］ Sekiguchi M, Kurabayashi M, Adachi H, et al. Usefulness of insulin resistance measured by homeostasis model assessment in predicting restenosis after coronary stent placement in nondiabetic patients［J］. Am J Cardiol,2004,93(7):920-922.

［4］ 金文胜，潘长玉，陆菊明，等.葡萄糖耐量低减与动脉粥样硬化［J］.中华内分泌代谢杂志,2004，20（2）：136-139.

［5］ Walcher D, Marx N. Insulin resistance and cardiovascular disease: the role of PPARgamma activators beyond their anti-diabetic action［J］. Diab Vasc Dis Res,2004,1(2):76-81.

［6］ UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive bloodglucose control with metformin on complications in overweight patients with type 2 diabetes(UKPDS 34) ［J］. Lancet,1998,352(9131):854-865.

［7］ Bastard JP, Pieroni L, Hainque B. Relationship between plasma plaminogen activator inhibitor 1 and insulin resistance［J］. Diabetes Metab Res Rev,2000,16(3):192-201.

［8］ Aso Y, Matsumoto S, Fujiwara Y, et al. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor1［J］. Metabolism,2002,51(4):471-476.

［9］ Osman A,Otero J,Brizolara A, et al. Effect of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes［J］. Am Heart J,2004,147(5):e23.

［10］Hadigan C, Meigs JB, Rabe J, et al. Increased PAI1 and tPA antigen levels are reduced with metformin therapy in HIVinfected patients with fat redistribution and insulin resistance［J］. J Clin Endocrinol Metab,2001, 86(2):939-943.

［11］易勇，陈玉成, 曾智. 冠脉支架内再狭窄防治研究进展［J］.心脏杂志，2003，15（6）：560－562.

备注/Memo

备注/Memo:
收稿日期：2006-10-20.通讯作者：罗明，主任医师，主要从事慢性心衰治疗研究Email:lmfc84@yahoo.com.cn 作者简介：王旭辉，主治医师，硕士生Email：huanzi318@sohu.com
更新日期/Last Update: